Abstract
Objective: Intrathecal administration of calcium channel antagonists has been proposed to reduce cerebral vasospasm (CVS) in animal subarachnoid hemorrhage (SAH) models. Also, delayed CVS treatment model with oral administration of cilostazol can be seen in the literature.
Methods: In this study, 25 male New Zealand white rabbits were randomly assigned to five groups: control, SAH only, SAH/nimodipine, SAH/cilostazol, SAH/vehicle. The animals’ basilar arteries were sectioned from four separate zones and four sections were obtained from each rabbit. Basilar artery luminal section areas were measured by using SPOT for windows Version 4.1 computer program.
Results: Basilar artery luminal section areas in SAH/ nimodipine and SAH/ cilostazol groups were significantly higher than SAH only group (P < 0.05).
Conclusion: Phosphodiesterase 3 inhibitor cilostazol has vasodilatory effects without affecting cerebral blood flow. Nimodipine is a calcium channel blocker and is still used in vasospasm therapy either oral or intravenously. This study demonstrates that prophylactic bolus intrathecal administration of either cilostazol or nimodipine equally prevents SAH-associated CVS in an animal model. We therefore propose that cilostazol is a candidate for clinical trials in the treatment of delayed vasospasm.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases.Neurosurgery 2001;48(4):723–8; discussion 728–730.
Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol. 2004;25(5):819–826.
Belen D, Besalti O, Yiğitkanli K, Kösemehmetoğlu K, Simşek S, Bolay H. Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage. Acta Neurochir (Wien). 2007;149(10):1041–7; discussion 1047–1048.
Bilginer B, Onal MB, Yigitkanli K, Soylemezoglu F, Bavbek M, Ziyal IM, et al. Treatment of cerebral vasospasm with cilostazol in subarachnoid hemorrhage model. Acta Neurochir Suppl. 2008;104:291–295.
Birk S, Kruuse C, Petersen KA, Jonassen O, Tfelt-Hansen P, Olesen J. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab. 2004;24(12):1352–1358.
Choi JM, Shin HK, Kim KY, Lee JH, Hong KW. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther. 2002;300(3):787–793.
Conti A, Angileri FF, Longo M, Pitrone A, Granata F, La Rosa G Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report.Acta Neurochir (Wien). 2008;150(11):1197–1202; discussion 1202.
Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial Circulation 1998;18;98(7):678–686.
Dorsch NW Cerebral arterial spasm – a clinical review. Br J Neurosurg. 1995;9(3):403–412.
Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F. Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. Am J Neuroradiol. 2005;26(6):1357–1362.
Gioia AE, White RP, Bakhtian B, Robertson JT. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg. 1985;62(5):721–728.
Gulsen S, Inci S, Yuruk S, Yasar U, Ozgen T. Effect of raloxifene on cerebral vasospasm following experimental subarachnoid hemorrhage in rats. Neurol Med Chir (Tokyo). 2007;47(12):537–542; discussion 542.
Ishida T, Takanashi Y, Kiwada H. Safe and efficient drug delivery system with liposomes for Intrathecal application of an antivasospastic drug, fasudil. Biol Pharm Bull. 2006;29(3):397–402.
Ito H, Fukunaga M, Suzuki H, Miyakoda G, Ishikawa M, Yabuuchi Y, et al. Effect of cilostazol on delayed cerebral vasospasm after subarachnoid hemorrhage in rats: evaluation using black blood magnetic resonance imaging. Neurobiol Dis. 2008;32(1):157–161.
Kim KY, Shin HK, Choi JM, Hong KW. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J Pharmacol Exp Ther. 2002;300(2):709–715.
Komotar RJ, Zacharia BE, Valhora R, Mocco J, Connolly ES Jr. Advances in vasospasm treatment and prevention. J Neurol Sci. 2007;261(1–2):134–142.
Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo.Intensive Care Med. 2008;34(5):932–938.
Mayer TE, Dichgans M, Straube A, Birnbaum T, Müller-Schunk S, Hamann GF, et al. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm. Cardiovasc Intervent Radiol. 2008;31(6):1200–1204.
Mori K, Miyazaki M, Iwata J, Yamamoto T, Nakao Y. Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat. Neurosurg Rev. 2008;31(2):197–203; discussion 203.
Moskowitz SI, Ahrens C, Provencio JJ, Chow M, Rasmussen PA. Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2009;71(3):311–317, discussion 317–318.
Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298(6674):636–642.
Seçkin H, Yigitkanli K, Besalti O, Kosemehmetoglu K, Ozturk E, Simsek S, et al. Lamotrigine attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Surg Neurol. 2008;70(4):344–351; discussion 351.
Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa A. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev. 2001;24(4):180–184.
Takanashi Y, Ishida T, Meguro T, Kirchmeier MJ, Allen TM, Zhang JH. Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J Clin Neurosci. 2001;8(6):557–561.
Takei K, Tokuyama K, Kato M, Morikawa. A role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages. Pharmacology 1998;57(1):1–7.
Tanaka K, Gotoh F, Fukuuchi Y, Amano T, Uematsu D, Kawamura J, et al. Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia. Stroke 1989;20(5):668–673.
Vinall PE, Michele JJ, Gordon DA, Simeone FA. Comparison of intraluminally versus extraluminally administered nimodipine on serotonin-induced cerebral vascular responses in vitro and in situ. Stroke 1989;20(8):1065–1070.
Voldby B, Petersen OF, Buhl M, Jakobsen P, Ostergaard R. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine).Acta Neurochir (Wien). 1984;70(3–4):243–254.
Vorkapic P, Bevan JA, Bevan RD. Two indices of functional damage of the artery wall parallel the time course of irreversible narrowing in experimental vasospasm in the rabbit. Blood Vessels 1991;28(1–3):179–182.
Xiong R, Lu W, Li J, Wang P, Xu R, Chen T. Preparation and characterization of intravenously injectable Nimodipine nanosuspension. Int J Pharm. 2008;350(1–2):338–343.
Zabramski J, Spetzler RF, Bonstelle C. Chronic cerebral vasospasm: effect of calcium antagonists. Neurosurgery. 1986;18(2):129–135.
Acknowledgement
This study was founded by Turkish Neurosurgery Society.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag/Wien
About this paper
Cite this paper
Onal, M.B., Bilginer, B., Narin, F., Ziyal, M.İ., Soylemezoglu, F., Ozgen, T. (2011). Comparison of Intrathecal Cilostazol and Nimodipine Treatments in Subarachnoid Hemorrhage: An Experimental Study in Rabbits. In: Feng, H., Mao, Y., Zhang, J.H. (eds) Early Brain Injury or Cerebral Vasospasm. Acta Neurochirurgica Supplements, vol 110/2. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0356-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0356-2_9
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0355-5
Online ISBN: 978-3-7091-0356-2
eBook Packages: MedicineMedicine (R0)